New York A 1055: Relates to the availability of buprenorphine in opioid treatment programs

Status: REFERRED TO WAYS AND MEANS (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: A 1055

Sponsors: Linda Rosenthal

View New York A 1055 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.